ROTEM指导肝硬化侵入性操作围术期输血随机对照试验
该随机对照试验纳入99例肝硬化患者共114次侵入性操作,比较ROTEM指导与标准治疗输血策略。ROTEM组预防性输血比例显著低于标准治疗组(71% vs 97%,P<.01),且未增加操作相关出血、血栓形成或死亡率。
要点
- ROTEM指导可显著减少肝硬化侵入性操作前的预防性血制品输注。
- ROTEM组更多使用冷沉淀、更少使用新鲜冰冻血浆。
- 两组均未记录到大出血,安全性与标准治疗相当。
核心结论
- ROTEM指导的输血策略在肝硬化患者侵入性操作中显著减少血制品使用且不损害安全性。
研究设计与样本
- 随机对照试验,99例肝硬化患者共114次侵入性操作被筛选,57次操作随机分组(ROTEM组28次,标准治疗组29次)。
主要发现
- ROTEM组20次操作前接受预防性血制品,标准治疗组28次(71% vs 97%,P<.01)。
- ROTEM组新鲜冰冻血浆使用较少而冷沉淀使用较多,血制品使用模式与标准治疗组不同。
- 两组在操作相关出血(均无大出血记录)、血栓形成、输血相关并发症、住院时间或死亡率方面无差异。
关键数值与推荐
- 44次操作(77%)被归类为高出血风险。
临床怎么用
- 对肝硬化患者侵入性操作围术期可采用更保守的ROTEM指导目标导向止血管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Periprocedural blood component(s) prophylaxis is common in patients with cirrhosis undergoing invasive procedures. We evaluated whether a rotational thromboelastometry (ROTEM)-guided algorithm could reduce prophylactic transfusions without increasing bleeding complications. METHODS: In this randomized controlled trial, adults with cirrhosis scheduled for invasive procedures with abnormal international normalized ratio and/or platelet count values requiring preprocedural correction as per standard local practice were randomized 1:1 to a ROTEM-guided or standard-of-care (SOC) transfusion strategy. The primary efficacy outcome was the proportion of procedures that required prophylactic transfusion of blood components(s). The primary safety outcome was major procedure-related bleeding. Secondary outcomes included type and volume of blood products transfused, transfusion reactions, thrombosis, and 28-day mortality. RESULTS: A total of 114 procedures in 99 patients were screened with 57 randomized (28 in ROTEM, 29 in SOC). Forty-four procedures (77%) were classified as having a high bleeding risk. Prophylactic blood products were administered before 20 procedures in the ROTEM group compared with 28 in the SOC group (71% vs 97%; P < .01). The pattern of blood product use differed between the groups, with less fresh frozen plasma and more cryoprecipitate in the ROTEM group than in the SOC group. There was no difference in procedure-related bleeding (no major bleeding was recorded), thrombosis, transfusion-related complications, length of stay, or mortality between the 2 groups. CONCLUSIONS: ROTEM-guided transfusion significantly reduced blood product use without compromising safety in patients with cirrhosis undergoing invasive procedures. These findings support a more conservative, goal-directed approach to periprocedural hemostatic management in patients with cirrhosis. Registered with the Australian New Zealand Clinical Trials Registry (ANZCTR; ACTRN12619000644167; https://www.anzctr.org.au/).
引用
- Janko N, Kemp W, Strasser SI, et al. Rotational Thromboelastometry-Guided Blood Product Transfusion in Patients With Cirrhosis Having Invasive Procedures: A Randomized Controlled Trial. Clin Gastroenterol Hepatol. 2026. PMID: 42624392. doi:10.1016/j.cgh.2026.07.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。